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Abstract. 
 
Green-fluorescent protein (GFP) labeled marrow cells transplanted into lethally irradiated mice 
can be detected in the lungs of transplanted mice and have been shown to express lung specific 
proteins while lacking the expression of hematopoietic markers. We have studied marrow cells 
induced to transit cell cycle by exposure to IL-3, IL-6, IL-11 and steel factor at different times of 
culture corresponding to different phases of cell cycle. We have found that marrow cells at the 
G1/S interface have a 3-fold increase in cells which assume a lung phenotype and that this 
increase is no longer seen in late S/G2. These cells have been characterized as GFP+CD45- and 
GFP+ cytokeratin+. Thus marrow cells with the capacity to convert into cells with a lung phenotype 
after transplantation show a reversible increase with cytokine induced cell cycle transit. 
Previous studies have shown the phenotype of bone marrow stem cells fluctuates reversibly as 
these cells traverse cell cycle, leading to a continuum model of stem cell regulation. The present 
studies indicate that marrow stem cell production of nonhematopoietic cells also fluctuates on a 
continuum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Marrow stem /progenitor cell regulation has classically been felt to be on a hierarchical basis (1-
3). Recent studies on the ability of marrow cells to produce both hematopoietic and 
nonhematopoietic cells in a variety of tissues, including skeletal muscle (4-7), liver (8-10), and 
lung (11-13) have raised controversial issues as to the inherent plasticity of adult marrow stem 
cells and challenged basic hierarchical models. 
 
In many respects the marrow stem cell has been defined by its ability to home to marrow of 
irradiated or nonirradiated mice. Transplanted cells distribute in the vasculature of the mouse and 
it has been estimated that from 6 to 9 % of infused stem cells end up residing in the marrow 
(14,15 ) These homing events are then followed by stable marrow engraftment. Habibian et al (16 
) demonstrated that marrow cells stimulated in vitro with cytokines and driven through cell cycle 
showed a reversible defect in engraftment at 26-32 hours of in vitro culture which then returned to 
baseline input values at latter time points in culture. The cells showing an engraftment defect 
were in late S/early G2 while normal engraftment was seen in G1. Cerny et al (14) showed that a 
defect in homing probably was responsible for the observed cell cycle related defect in 
engraftment. 
 
In studies focused on the hematopoietic system, we have found that the phenotype of primitive 
marrow stem cells fluctuates reversibly with cell cycle transit (17-21). As noted above, the 
engraftment capacity of stem cells reversibly changes as stem cells transit cycle (16, 22) and 
there are also alterations in homing (14). Adhesion protein expression (23, 24), global gene 
expression (22), and progenitor numbers (25) are also tied to different phases of cell cycle. 
Progenitor cell levels and engraftment capacity showed an inverse relationship (25).  In addition, 
the capacity of stem cells to differentiate into megakaryocytes and granulocytes was tied closely 
to specific points in cell cycle and was also reversible (26). These observations might be of less 
biologic significance if the marrow stem cell was a quiescent non-cycling cell, as has been dogma 
over the years. However, this is not the case. Definitive studies by Bradford and colleagues (27),  
confirmed by others (28, 29 ), showed that a quiescent primitive marrow stem cell population, the 
lineage-negative, rhodaminelow  Hoechstlow  (LRH) cell, is either continually or intermittently in cell 
cycle. Bradford et al (27) provided BrdU in the drinking water of mice, subsequently sacrificed the 
mice, and determined BrdU labeling of LRH. They found that there was 60% labeling by 4 weeks. 
Work by Cheshire et al (28), using a different mouse strain and stem cell separation, confirmed 
this work, but showed more rapid labeling kinetics. This is consistent with the work of Fleming et 
al (30) showing that 18-22 % of Thy1.1lo Lin-/loSca-1+ marrow cells have over 2 N DNA content. 
These observations indicate that stem cells continuously alter phenotype as they progress 
through cell cycle and that these alterations are reversible. Stem cells are in cycle, so presumably 
the in vivo phenotype of the marrow stem cell is constantly changing over time. This has led to a 
continuum model of stem cell regulation in which a change in phenotype is tied to cycle related 
changes in transcription factor access to different promoter regions (17-21). This is also 
consistent with the phase-space model of Kirkland (31) and the stochastic model of Roeder and 
colleagues (32). 
 
Marrow cell production of lung cells has also been reported by many groups, although the 
quantitative extent of such events has varied widely. We have reported on the production of lung 
cells by marrow cells in irradiated mice (13) and demonstrated that these results were not due to 
false reading of auto fluorescence or due to misinterpretation of sections with overlapping cells.  
The latter was addressed using deconvolution fluorescent microscopy. In essence, we have 
engrafted green-fluorescent protein (GFP) transgenic marrow into lethally irradiated C57BL/6 
mice, and shown that 3.4 to 5.43% of cells within the lung are GFP+ CD45-, which we have 
defined as being donor marrow derived lung cells.  Sixty percent of these cells are also 
cytokeratin positive suggesting that these cells are donor derived pulmonary epithelial cells.  We 
have also shown that administration of G-CSF with stem cell mobilization increases the number 
of donor-derived GFP+CD45- cells to 7.48%.  These data, along with reports by others (11-13), 
indicate that bone marrow cells have the capacity in vivo to produce nonhematopoietic lung cells 
with epithelial markers. In the present study, we have addressed whether this converting capacity 
of marrow into lung would vary with cell cycle status. We have addressed both early homing to 
lung and long term engraftment fates of marrow cells in lung. 
 
Results:  
 
Homing and Persistence 
 
 We assessed homing of freshly isolated and cultured (IL-3, IL-6, IL-11 and steel factor) lin-Sca-1+ 
marrow cells to lung at 3 hours, 7, and 14 days. In these studies, CFSE or GFP+ cells were 
followed and fluorescent events per tissue section or marrow cell population recorded. Host 
recipient mice were either untreated or exposed to 1000 cGy whole body irradiation. In 
nonirradiated mice, homing to the lung was significantly increased at 24 hours of culture (p<0.05) 
(Fig. 1 C&D), which, corresponds to G1/S interface (Fig. 1A). It had returned to baseline by 40 
hours (Fig. 1D). The elevation of homed Lin-Sca-1+ cells at 24 hours of culture was confirmed in 
two separate experiments in which lung cells were analyzed by flow cytometry. There was a 
mean 1833% increase at 24 hours. Bone marrow homing at 18 and 24 hours is decreased (Fig. 
1B). Homing in liver, spleen and heart did not show dramatic increases at 24 hours of culture (Fig 
1 C) 
 We evaluated homing and persistence of GFP+ Lin-Sca-1+ cells in lung  at 3 hours 7 days and 14 
days after cell infusion into irradiated (1000 cGy) mice(Fig 2 A-C). Fluorescent cells increased in 
number suggesting persistence of the initially homed cells. Thus, marrow cells home to lung and 
show persistence and an increase in number over the 2 weeks post-cell infusion. We also 
showed clustering of donor cells at 14 days suggestive of donor derived colonies (Fig. 2 D&E). 
These data indicate that there is an increased number of stem cells homed to the lung at 24 
hours of culture at the G1/S interface. 
 
Autofluorescence and Overlap of Cells 
 
We evaluated the capacity of either purified GFP+ Lin- Sca-1+ cells or whole bone marrow (WBM) 
cells to engraft in lung and demonstrate a nonhematopoietic phenotype by quantitating 
GFP+CD45- cells in frozen  or paraffin sections of lung from transplanted mice. We first 
established the validity of our cell tracking and identification approaches.  We transplanted 
250,000 GFP+ Lin- Sca-1+ cells or the cultured volume equivalent, along with 200,000 WBM as 
helper cells, into 900 cGy irradiated mice.  We then evaluated the lungs 9-12 weeks after initial 
cell infusion.  Samples were examined using a  fluorescent microscope with filter sets as follows: 
DAPI, FITC, Texas Red and a FITC/Texas Red double bandpass.  The slides were examined 
using all filters however the double band pass filter was heavily utilized for discriminating true 
fluorescent signal from autofluorescence.  Since autofluorescence emits signal across many 
wavelengths it is seen in both the FITC and the Texas Red filters. True fluorescent signal should 
only be visualized in the filter designed for it.  This method of distinguishing autofluorescence 
from true signal has been validated in the literature (33).  With the doubleband pass filter two 
colors, green and red, are visualized simultaneously. Any autofluorescence seen in this filter 
appears yellow/orange (as it emits at many wavelengths) (Fig. 3).  We examined our samples 
under confocal microscopy but found that although monochrome cameras used in confocal 
imaging offered superior resolution and dynamic range, they were not suitable for scoring 
samples as they are incapable of distinguishing true signal from autofluorescence.  As stated 
above, we used a FITC/Texas Red double bandpass filter for scoring samples and used 
deconvolution microscopy for high resolution images.  These images where acquired with a high 
resolution monochrome camera only after verification of true signal using standard filters and the 
double bandpass filter. 
 
In Figure 4 A-D, DAPI positive cells (nucleus present) which are also GFP+ are shown.  One of 
the cells (4D) is also cytokeratin positive. Deconvolution fluorescent microscopy is used to 
demonstrate colocalization of DAPI, GFP and cytokeratin and this is also shown utilizing 
deconvolution fluorescent microscopy (Fig. 4E). 
 
We have previously addressed the issue of autofluorescence using rhodamine (red) anti-GFP 
antibodies to determine whether green fluorescing cells were expressing GFP protein or were 
examples of autofluorescence. In summary, under the conditions of our experiments, 
autofluorescence was rare or not seen and if present was excluded from the counts by use of the 
double bandpass filter(13 ). The geographical location of the GFP positive cells is shown in 
Figure 5. Donor hematopoietic cells (GFP+CD45+) , host hematopoietic cells (GFP-CD45+) and 
donor cells with a nonhematopoietic phenotype (GFP+CD45-) are seen distributed at different 
locations in the alveolar walls. 
 
Engraftment studies 
 
Wild type C57BL/6 mice were exposed to 900-1000 cGy  whole body irradiation and then infused 
with either 5X106 green-fluorescent protein (GFP) positive (GFP+) WBM cells or with 250,000 
lineage negative, Sca-1+ GFP+ marrow cells  plus 200,000 wild type C57BL/6 WBM cells. Three 
weeks later mice were injected with granulocyte colony stimulating factor (G-CSF) (250 µg/Kg) 
subcutaneously daily for 5 days. Mice were then administered intratracheal bleomycin, 
intramuscular cardiotoxin or no treatment with a subsequent 5 day course of G-CSF. The mice 
were then sacrificed 2 months after transplantation. We found that the number of CD45- donor 
cells in the cardiotoxin group (n=17) was not significantly different from those in the non 
cardiotoxin group (n=16) so the results from these groups have been combined.  The bleomycin-
treated mice (2 mice) gave similar results to that seen with the cardiotoxin mice and these results 
were included in the combined results.  In one experiment a lower dose of cytokines was utilized, 
again with identical results.  
The number of GFP+CD45- lung events varied significantly between experiments for uncultured 
cells (time 0 group), ranging from 0.84 to 22.5% for WBM and from 0.37 to 1.55 for Lin-Sca-1+ 
cells. For the evaluation of changes over time in culture, these data were normalized as a % of 
the time 0 values. 
Values for total GFP+ cells per DAPI+ cell (nucleated), normalized to time 0 values are presented 
in Table I.  The absolute mean percentage +/- one standard error of the mean for total GFP+ 
events in the lungs at time 0 in the WBM only experiments was 22.6+/-1.8% of all DAPI+ cells. 
The majority of these GFP+ cells (75%), were hematopoietic cells (CD45+).. When Lin-Sca-1+ 
marrow cells were transplanted, 11+/-3 percent of the DAPI positive events were GFP+ and of 
these 87.3%  were GFP+CD45+ . When all groups were combined (WBM and Lin-Sca-1+ groups), 
the number of GFP+ cells per DAPI positive cells  at time 0 was 21+/-1.9% and 74 % of these 
were GFP+CD45+. The changes over time as a percent of time 0 are shown in Table I. There 
were significant increases for GFP+ lung events when either WBM or Lin-Sca-1+ groups were 
infused after 24 hours culture in IL-3, IL-6, IL-11 and steel factor (G1/S) (P<0.05).  
We were particularly interested in the GFP+CD45- population of cells in the lungs of transplanted 
mice, since these cells represent marrow donor derived cells which no longer have a 
hematopoietic phenotype. As noted above, the observed events were not due to 
autofluorescence or overlapping cells. While the number of GFP+CD45- events per DAPI+ cell 
varied between experiments, when the results were normalized and expressed as a percent of 
time 0, there was a marked increase in GFP+CD45- events when 24 hour cultured marrow cells 
were compared to time 0. There was then a return to baseline at 48 hours. Data from WBM, Lin- 
Sca-1+ and the combined groups are presented in Figure 6. See figure legends for statistics. 
 
When the same data was analyzed and presented per culture experiment , instead of based upon 
the individual transplanted mice, the same conclusions were reached; there was a significant 
increase in GFP+CD45- cells/DAPI+ cell in the lungs of mice transplanted with 24 hour cultured 
cells.  This increase was not seen at 48 hours (Fig. 7). 
 
We have also confirmed this 24 hour G1/S increase in donor-derived nonhematopoieitc lung cells 
using a different and simpler model in which mice were irradiated with 900 cGy whole body 
irradiation and then sacrificed 6 weeks later. No mobilization was used. We again saw a marked 
increase in events in the 24 hour LI-3, IL-6, IL11 and steel factor cultured group (Figure 8). 
 
There was a significant increase (p<0.05) in the number of GFP+/cytokeratin+ cells (donor-derived 
pulmonary epithelial cells) in the lungs of mice transplanted with 24 hour cultured cells.  This level 
returned to baseline in the 48 hour group (Fig. 9). 
 
Real Time RT- PCR for Lung Markers 
 
Total RNA was isolated from Lin-Sca-1+ murine marrow cells at 0, 24 and 48 hours of culture in 
IL-3,IL-6, IL-11 and steel factor and Real Time ( RT-PCR) carried out to determine mRNA levels 
for different lung specific proteins. mRNA for Clara-cell protein, cytokeratin 14, cytokeratin 5 and 
surfactant B were not detected at any time point, while Pecam was detected but unchanged at 
the different time points. Col 1 was also detected at time 0 and was decreased thereafter. 
 
 
Marrow/Lung cell fusion studies 
 
In lethally-irradiated mice that received WBM cells from female donors, we found no cells within 
their lungs that were GFP+ and XXXY+. Samples were analyzed for the presence of cells of both 
donor (female) and recipient (male) origin and were defined as nucleated cells (DAPI+) that were 
XXXY+.  Five to 10 HPF were analyzed from each of the 5 male bone marrow recipients using 
both standard fluorescence and deconvolution microscopy.  Over 5,000 total nuclei were 
visualized.  Three dimensional images of some cells were created from a 25 stack layer 
(0.4µm/layer) Z-stack to rule out fluorescent signal from adjacent cells.  Lung samples from 
female recipients were also analyzed in a similar fashion for the presence of fused cells (XXXX+). 
In addition, lethally-irradiated female mice that received WBM cells from female donors had no 
GFP+XXXX+ cells within the lungs. These findings suggest that fusion did not significantly 
contribute to the presence of donor marrow-derived lung cells. 
 
Discussion: 
 
The phenotype of bone marrow stem cells is labile with a cytokine induced passage through cell 
cycle. It shows reversible modulation, and this has led to the concept that marrow stem cells may 
be regulated on a continuum, rather than in a hierarchy (17-21). These observations have, until 
now, been restricted to hematopoietic phenotypes with reversibility of function within the 
hematopoietic tissue. In their “quantitative stem cell modeling” Roeder et al (32) describe “within-
tissue plasticity”, which is consistent with our previous studies on the hematopoietic phenotype of 
cycling stem cells. Kirkland (31), with his phase space model of hematopoiesis, has also 
emphasized the lability of the marrow stem cell phenotype. 
  
The present data indicate that a cycle related phenotype modulation of marrow stem cells 
extends to nonhematopoietic cells and tissues.  We have shown here that engrafting marrow 
stem cells in the G1/S interface have a capacity to form non-hematopoietic cells in lung tissue 
that is approximately three times that of the quiescent freshly isolated noncultured cells (Figs 5-
7). This increased capacity to make lung cells is not fixed, but changes over time and at 48 hours 
of culture (lateS/G2) has returned to baseline. Thus this represents a reversible shift in 
differentiation tied to cell cycle. 
 
Our results have to be viewed within the context of the controversial area of stem cell plasticity. 
Major criticisms of this area of research have been raised including the robustness of the 
phenomena, the accuracy of cell identification, and the difficulty in demonstrating 
transdifferentiation (34-36) In addition, it has been suggested that if fusion is involved or if the 
studies have not been carried out clonally, the phenomena is meaningless. We have addressed 
these issues recently in a perspective entitled, “Ignoratio Elenchi” (37). This means red herrings. 
To reiterate: robustness is a relative phrase, clonal studies  address heterogeneity, and many 
investigators have appropriately identified donor cells in their experiments. 
Furthermore, fusion is simply a mechanism to an end; operative in some models and not in 
others, Fusion appears not to be operative in the context of the studies presented here.  
We have specifically addressed the concerns of auto fluorescence and overlapping cells in our 
studies (38,13). In Figure 4 we show colocalization of cytokeratin and GFP signals. We have not 
found overlapping cells to be a confounding variable. In previously reported work, we have shown 
a virtually total concordance of green GFP signal with red-rhodamine anit-GFP signal from 
transplanted cells and in our studies the rare autofluorescent event is screened out from counting 
by use of the double bandpass filter, as illustrated in Figure 3. 
These studies indicate that marrow cells produce nonhematopoietic cells at varying levels 
depending upon the experimental setup, but, in general, in the 3-5% range (13). Despite this 
variability in total numbers per section, there was a highly reproducible increase in lung donor 
derived nonhematopoietic cells, when cells transplanted in early-S phase were compared to cells 
transplanted immediately after isolation. A portion of these cells marked with cytokeratin and, 
thus, were pulmonary epithelial lung cells. These cytokeratin cells also showed a significant 
increase when G1/S phase cells were transplanted.  
 
The relationship of homing to the subsequent engraftment events remains unclear. In 
nonirradiated mice, there was an increase in homed Lin- Sca-1+ cells in early-S phase. This is the 
same time point in culture in which we see a later increase in donor marrow-derived cells with a 
nonhematopoietic or epithelial phenotype. The 1 and 2 week time points carried out in irradiated 
mice indicate that the cells which homed to lung persisted and increased in number, but do not 
tell us whether these cells were the critical cells for the later engraftment events or whether cells 
which initially homed to marrow were largely responsible for the donor lung cells with 
nonhematopoietic phenotype observed at 2 months post engraftment. Marrow cells which restore 
liver cells may first need to engraft in marrow (9). The reproducible augmentation seen with G-
CSF mobilization (13), which we have previously reported, is supportive of this view. Initial 
homing and later mobilization from the marrow may both be involved in the final engraftment 
results. 
 
The underlying mechanism for determining the lung hotspot remains an open question. Lung 
specific markers on marrow stem cells at the hotspot were undetectable, but this, does not 
address the potential of the cells at that point in time. During cell cycle passage chromatin/histone 
coverage continues to change so that different promoter regions are susceptible to transcriptional 
regulation (39-43). Changes in the final cell lineage after transplantation could then be 
determined by activation of specific promoters that could directly or indirectly lead marrow cells to 
form cells with a lung phenotype. A similar sequence of events may occur with the 
megakaryocyte hotspot observed when lineage negative rhodamine low Hoechst low cells are 
cultured in thrombopoietin, FLT3l and steel factor and then subcultured in G-CSF, GM-CSF and 
steel factor at the G1/S interface (26). It is also possible that at certain phases of cell cycle the 
cell expresses specific receptors which can receive external signals allowing for eventual lung cell 
differentiation. An increased propensity for cell fusion at particular points in cell cycle could also 
explain the increased number of GFP+CD45- or GFP+ cytokeratin+ lung events after 
transplantation , however our studies reported here, and those of others, rule against cell-cell 
fusional events (44,45).   More subtle fusional events with transfer of cellular elements remains a 
possibility. 
 
In summary, the present data indicate that the capacity of marrow cells to form cells in lung and 
adopt the phenotype of lung cells reversibly varies with time in cytokine culture and phase of cell 
cycle. This suggests that the continuum concept for marrow stem cells can be extended to 
nonhematopoietic cells. One could speculate that there may be differentiation hotspots for other 
nonhematopoietic cell types in the body and that these may be identified by studies of highly 
synchronized cycling stem cells.  
 
Materials and Methods 
 
Six-eight week old female or male C57BL/6 (H2Kb) or C57BL/-TgN(ACTbEGFP)1Osb mice were 
purchased from Jackson Laboratory (Bar Harbor) and bred in our animal facility by mating 
heterozygous GFP positive mice to C57BL/6 mice to produce GFP positive transgenic mice. 
Animals were certified to be pathogen-free. All animals were housed in micro-insulator cages, in a 
conventional clean facility for at least one week prior to experimental use. All studies were 
approved by the Institutional Animal Care and Use Committee of Roger Williams Medical Center,. 
Animals were given ad libitum access to food and  water. C57BL/6 mice were also obtained from 
Taconic Farms (Germantown, N.Y.) 
 
WBM transplants.  Male C57BL/6-TgN(ACTbEGFP)1Osb mice (GFP positive) were 
anesthetized followed  by cervical dislocation.  Bone marrow was flushed from tibiae, femurs, and 
iliac crests with phosphate-buffered saline (PBS) supplemented with 5% heat inactivated fetal calf 
serum (HI FCS); Hyclone, Logan, VT) using a 22.5-gauge needle.   Host C57BL/6 male mice 
received lethal irradiation with 900 cGy total body irradiation (TBI) give as a single dose or 
1000cGy TBI given as a split dose of 500 cGy 3 to 4 hours apart.  Irradiation was done using a 
linear accelerator or a gammacell 40 irradiator (MDS Nordion, Canada).  Each host animal 
received 5 x 106 WBM from the GFP donors.  
 
Stem cell harvest .  Six to 8-week old male mice were killed by cervical dislocation. BM was 
collected from spines, femurs, tibiae, and iliac crests. Bones were ground in phosphate-buffered 
saline (PBS) supplemented with 5% heat inactivated fetal calf serum (HI FCS); (Hyclone, Logan, 
VT) using a mortar and pestle. The bone fragments were washed multiple times and the 
supernatant cell suspension and wash fractions strained through a 40-µm filter to remove large 
bone particles. High lipid concentrations were reduced by centrifugation and resuspension of the 
cells in fresh buffer. The cellular suspension was incubated on ice for 3 minutes, so that small 
bone particles could settle out. The cell supernatant was then diluted to107 cells/ml PBS, 5% HI 
FCS.   
 
Lineage negative cells were isolated as previously described (25). Low density marrow cells 
(<1.077 g/cm3) were isolated by discontinuous density centrifugation using 1-Step for animals 
(Accurate Chemical and Scientific Corp., Westbury, NY) or Optiprep ( Accurate Chemical and 
Scientific Corp., Westbury, NY), washed, and resuspended at 108 cells/ml in PBS 5% HI FCS. 
Cells were labeled with a cocktail of primary rat antibodies: anti-B220 (B cells), anti-MAC-1 
(macrophages and neutrophils), anti-GR1 (neutrophils), anti-Lyt-2 (CD8 T-cells), anti-L3T4 (CD4-
T-cells) and Ter119 (erythrocytes precursors).  After 15-minute incubation on ice, the labeled 
cells were washed in PBS 5% HI FCS and resuspended at 108 cells/ml in PBS 5% HI FCS. The 
cells were incubated with sheep anti-rat IgG conjugated immunomagnetic polystyrene spheres 
(M-450 Dynabeads; Dynal, Lake Success, NY) according to manufacturer instructions.  
Immunomagnetic bead-rosetted cells were removed using a magnetic particle concentrator 
(Dynal, MPC-6) and the unrosetted cells remaining in suspension were harvested. The beads 
were washed three times and the supernatant pooled with the cell suspension.   
 
Lin- Sca-1+ Separation.  Immunomagnetically lineage depleted cell suspensions were washed 
and resuspended at cell concentrations of 3 to 5 x 106 cells per ml in PBS 5% HI FCS and 
incubated with biotin anti-mouse Sca-1 (BD Pharmingen; stock 0.5mg/ml) antibody at a 
concentration of 2.5 µg/ml for 20 minutes on ice.  The cells were washed again resuspended at 3 
to 5 x 106 cells per ml in PBS 5% HI FCS and incubated with streptavidin allophyocyanin 
(Molecular Probes; stock 1mg/ml) at a concentration of 5µg/ml for 20 minutes on ice in the dark.  
The cells were then washed with ice-cold PBS 5% HI FCS and resuspended in PBS containing 1 
μg/ml propidium iodide (PI; Sigma Chemical Co., St. Louis, MO). The sample was filtered through 
a 35 μm small blue cap filter (Falcon Cat # 2235). Fluorescence-activated cell sorting was 
performed on a MoFlo cell sorter (Cytomation, Fort Collins, CO).  Lineage negative cells were 
sequentially selected for sorting as PI- and Sca-1+. 
 
Cytokine stimulated cell culture.  WBM (1-5 x106 /ml.) or Lin- Sca-1+  marrow cells were 
established in Teflon (non-adherent) bottle cultures with DMEM + 15% HI FCS+ 1% penicillin + 
1% streptomycin + 1% L-glutamine and cytokines at the following concentrations; recombinant 
mouse (rm) IL-3, 50 U/ml, recombinant mouse IL-11, 50 ng/ml, rmIL-6, 50 U/ml and rm steel 
factor 50 ng/ml.  Cultures were harvested at 0 hour (time 0, before culture) 24, 40, and 48 hours. 
In one experiment 100 fold lower levels of cytokines were used with qualitatively similar results. 
The cells were washed, resuspended at 2 x106 cells/ml (based on culture volume) in sterile PBS, 
and then immediately infused via tail vein injection. 
 
Homing Assay.  Lin-Sca-1+ cells were labeled with 5(6)-carboxyfluorescein diacetate N-
succinidyl ester (CFSE) (Molecular Probes, Eugene, OR) (46).  Cells were suspended at a 
concentration of 1-5  x106 cells/ml in pre-warmed PBS containing 2 μM CFSE. Labeling was 
carried out at 37° C for 15 minutes and stopped by adding several volumes of ice-cold Hanks’ 
balanced salt solution (HBSS) containing 10% fetal calf sera (FCS). CFSE labeled cells were 
recovered after centrifugation and resuspended at a concentration of 1X106 /ml in sterile saline. 
Cells were kept on ice and protected from light until infusion. The presence of CFSE labeled cells 
in host tissues was determined three hours after cell infusion either by flow cytometry (marrow 
cells) or by fluorescent microscopy of frozen sections of lung, liver, spleen, heart, thymus, and 
skeletal muscle.  
 
Persistence Assay.  Cell infusions were structured as above but GFP+ cells were utilized in 
order to track cells at 7 and 14 day intervals after cell infusion. Cell tracking was accomplished by 
scoring fluorescent events on frozen lung sections. 
 
Determination of capacity of cycling marrow cells to produce lung cells.  Whole uncultured 
marrow or Lin-Sca-1+ GFP+ marrow cells or cultured (24 or 48 hours) GFP+ marrow cells (see 
above) were infused via tail vein into C57BL/6 hosts that received 900 or 1000cGy irradiation 
(split dose 3 or 4 hours apart) on day 0.  Recipient mice then received G-CSF ( 250µg/kg) for 5 
days followed by either no injury, intratracheal bleomycin (Blenoxane®, Britol-Myers-Squibb 
Princeton, NJ 2 units/kg) or intramuscular cardiotoxin (10mM final)  into anterior tibialis muscle 
followed by another 5 days of G-CSF. Two months after cell infusion mice were sacrificed and 
lungs evaluated for GFP+ events.  In one experiment mice were engrafted and analyzed 6 weeks 
later without other interventions. 
 
Organ harvest.  Mice were anesthetized using intraperitoneal ketamine/xylazine.  Red blood 
cells were removed from the lungs by slow perfusion with PBS into the right ventricle, followed by 
perfusion of the left ventricle.  Ice-cold 4% paraformaldehyde was infused into the lungs through a 
small hole in the trachea.  A blunted 221/2-gague needle was used to deliver the 4% 
paraformaldehyde.  Inflation of the lungs in this fashion allowed for adequate fixation of epithelial 
surfaces and expanded airways and alveolar spaces, preserving morphology.   Once the heart 
and lungs were removed, the tissues were placed into ice-cold periodate–lysine–
paraformaldehyde (PLP).  The left lung and caudal lobe of the right lung were cut into two pieces 
and the cranial, middle and accessory lobes of the right lung were left intact. The lungs were fixed 
in PLP shaking on ice for 2-3 hours and then placed in 7% sucrose over night at 4°C followed by 
imbedding in frozen section medium the next morning pieces were kept at -70°C for storage.  
Lungs that were to be embedded in paraffin were dehydrated through graded ethanol then 
mineral spirits and finally embedded in paraffin wax.  
 
CD 45 staining.  Eight micrometer lung sections were mounted on either 0.01 % poly-L-lysine 
(Sigma, St Louis MO) or adhesive coated slides (Newcomer supply). Sections of lung were 
incubated at 37°C for 30 minutes then washed in PBS 2 times for 2 minutes at room temperature.  
Samples were blocked for avidin/biotin washed and incubated with primary antibody, biotin rat 
anti mouse CD45 (Pharmingen), at room temperature for one hour.  Slides were washed three 
times for 5 minutes in PBS at room temperature and incubated with Texas red avidin (Vector) at 
room temperature for 30 minutes.  The slides were then washed three times in PBS at room 
temperature and counter stained with Vectasheild and Dapi.  
 
Cytokeratin/CD45.  An antigen retrieval step was necessary for cytokeratin labeling and was 
performed by incubating samples in 20% Triton x-100 for 20 minutes at room temperature. When 
labeling lung samples for cytokeratin and CD45 it was necessary to amplify the CD45 signal 
using a TSA Biotin System (PerkinElmer Life Sciences).  Briefly, the samples were cut and 
prepared as above.   After the primary antibody was washed off, the samples were incubated with 
streptavidin HRP for thirty minutes at room temperature, washed with 0.05% TWEEN for 5 
minutes 3 times. They were incubated with Biotinyl Tyramide Reagent (Perkin Elmer Life 
Sciences) for 10 minutes then washed and processed as described above except that AMCA was 
used as a secondary for CD45.  Because of this no DAPI counter stain was done.   
 
Evaluating lung sections.  Donor GFP+/CD45 - or GFP+/cytokeratin+ cells were expressed as a 
percentage of the total number of DAPI positive cells and were counted by fluorescence 
microscopy.  Isotype and secondary only controls were performed for CD45 and cytokeratin. 
Expression of GFP and antigens stained by different fluorescent conjugated antibodies were 
visualized by standard fluorescent and deconvolution microscopy. In order to exclude 
autofluorescent cells, cells were evaluated using a double bandpass filter. CD45 and cytokeratin 
samples were also evaluated by confocal microscopy. The three dimensional images of cells 
were created from a 40 layer (0.2 µm/layer) Z-stack, in order to show colocalization of  green and 
red signals (GFP/cytokeratin).  
 
Marrow/Lung Cell Fusion Studies 
 
C57BL/6 mice where lethally irradiated with 900cGy TBI split dose 3 hours apart.  These mice 
were transplanted with 5x106 WBM cells obtained from male GFP+ mice as previously described.  
Two months later recipient lungs were harvested, inflation fixed and paraffin embedded as 
previously described.   Tissue analysis was done on 5-µm lung sections. Samples were 
deparaffinized  in xylene and ethanol then permeabilized with 0.3% Triton X for 15 minutes.  
Sections were then digested with Proteinase K for 5 minutes at 37°C and fixed in 4% 
paraformaldehyde for 5 minutes.  Prehybridization buffer, containing 150 mM sodium chloride, 15 
mM sodium citrate, 0.2 mM dextran sulfate (Sigma, St. Louis, MO), 4µg murine Cot 1 DNA 
(Invitrogen, Carlsbad, CA) and 150 mM dithiothreitol (DDT, Sigma), was added to each sample 
and incubated at 45°C for 1.5 hours.  Y chromosome probe (A gift from Dr. Ulli Weier, Lawrence 
Berkeley National Laboratory, Berkeley, CA) and FITC-conjugated mouse chromosome X probe 
(Cambrio, UK) were added to the prehybridization buffer and samples were denatured at 80°C for 
10 minutes.  Hybridization occurred overnight at 45°C.  The following day, samples were washed 
in 0.1x SSC (15 mM sodium chloride and 1.5 mM sodium citrate) for 1 hour  at 45°C.  Samples 
were blocked using a 5% fetal calf serum/5% non fat milk solution for 15 minutes.  The Y probe 
was detected using anti-digoxigenin rhodamine F(ab) fragments (Roche, Indianapolis, IN), diluted 
1:33 in 1XPBS/2% bovine serum albumin and added to each sample for 2 hours.  Samples were 
washed in 1XPBS and counterstained with Vectashield and DAPI.   
 
Evaluating lung sections for the presence of fused marrow/lung cells 
Samples from female to male transplants were analyzed for the presence of cells of both donor 
(female) and recipient (male) origin and were defined as nucleated cells (DAPI+) that were 
XXXY+.  Five to 10 HPF were analyzed from each of the 5 male bone marrow recipients using 
both standard fluorescence and deconvolution microscopy.  Over 5,000 total nuclei were 
visualized.  Three dimensional images of some cells were created from a Z-stack(25-layer)  to 
rule out fluorescent signal from adjacent cells.  Lung samples from female to female transplants 
were also analyzed in a similar fashion for the presence of fused cells (XXXX+). 
 
Real Time RT-PCR 
 
Total RNA was isolated from cultured cells, using RNeasy®Micro Kit (Qiagen Inc. Valencia, CA). 
Real Time reverse transcription-polymerase chain reaction (Real Time RT-PCR) was performed 
in a two step reaction. Reverse transcription was achieved with the TaqMan® RT Reagents kit ( 
Applied Biosystems, Foster City, CA) and the PCR reaction was performed using samplings from 
the same cDNA aliquot for multiple genes. Reactions for each specific gene were performed in 
triplicate to ensure reliability of data. Applied Biosystems’ predeveloped TaqMan® Gene 
Expression Assays were used in the PCR reaction for gene expression analysis. The TaqMan® 
assay is a 20X concentrated nucleotide mix which includes 2 unlabeled PCR primers (900nM 
each final concentration) and 1 FAMtm dye labeled TaqMan®MGB probe (250nM final 
concentration). The PCR reaction was carried out with the 2X TaqMan® PCR mastermix (Applied 
Biosystems) and 20X assay mix in 25ul reactions in the AB17000 Sequence Detection System 
(Applied Biosystems) on the same thermal profile of 50°Cx2min., 95°Cx10 min., 40 cycles (95°Cx 
15 sec., 60°Cx1min.). Beta-2 microglobulin was used as an endogenous control in conjunction 
with the genes of interest. 
 
Statistics.  Statistics were done using ANOVA for analysis of variance, if ANOVA showed a 
statistical significant result, posthoc tests were performed with Turkey’s test for all pairs 
comparisons. Dunnett’s test was used for comparisons of 24 and 48 hours against 0 hour. 
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Figure legends: 
 
Figure 1.  Homing of Lineage negative Sca-1 positive cells.   (A) Cell cycle analysis of Lin- 
Sca-1+ cells cultured in IL-3, IL-6, IL-11 and SCF at various time points. Cells were analyzed on a 
flow cytometer using ModFit LT cell cycle modeling software.   (B) Homing of CFSE labeled, Lin- 
Sca-1+ cells to bone marrow in non irradiated hosts, 3 hours post infusion.  Cells were either 
cultured for 0 (no culture), 18, 24, 40 or 48 hours in IL-3, IL-6, IL-11 and SCF prior to transplant. 
Analysis was done by flow cytometry for the presence of CFSE positive cells. (C) Homing of 
CFSE labeled, Lin-Sca-1+ cells to organs in non irradiated hosts, 3 hours post infusion. Cells were 
pretreated prior to transplant as described in (A) and presented as number of events per high 
powered field. Analysis was done by frozen sections and  CFSE positive cells counted per high 
powered field. (D) Analysis of homed Lin- Sca-1+ cells by frozen section presented as a percent of 
the time 0 control.  Cells were pretreated as described in A.  All error bars represent the standard 
deviation.  If no error bars is seen, the value represents less than 3 animals.   
ANOVA followed by Tukey multiple comparisons were done to compare the mean of %DAPI in 
lung at 0, 18 and 24 hours. The mean % DAPI were statistically significantly different at least 
between two of three time points (ANOVA p=0.007) and Tukey test shows that  a significant 
difference was observed between 0 and 24 hours (p<0.05). 
 
Figure 2. Homing and persistence of cultured GFP Lin- Sca-1+ cells to lung.   (A-D) Images 
are a combination of DAPI (blue), GFP (green) and phase contrast utilizing nomarski optics. (A-
C), 20x objective  (D) and (E) 63X objective. (A) Arrows indicate donor GFP positive Lin- Sca-1+ 
cells 3 hours post infusion. (B) Arrows indicate slight increase in GFP positive cells 7 days post 
infusion. (C) Arrows show an even larger increase in the number of GFP positive cells at 14 days 
post transplant and begin to show groups of positive cells.  (D) High magnification of a colony like 
(circle) formation of GFP cells at 14 weeks post transplant.  (E) Three dimensional deconvolution 
of D showing the close proximity of the positive cells.    
 
Figure 3. True fluorescence distinguished from autofluorescence.  Section of lung from an 
animal transplanted with GFP WBM. (A, B, C and D) Digital images of lung, taken with a Zeiss 
color digital camera. All pictures are from the same tissue section and same field of view, taken 
through different filters.  (A) DAPI alone. (B) FITC alone. (C) Texas Red alone. (D)  FITC/Texas 
Red double bandpass filter. Each numbered arrow corresponds with the same cell or area for all 
images.  Arrows 1 and 2 show clear examples of autofluorescence since the signal is visible both 
in the FITC (B) and the Texas Red (C) channels.  This false signal is easily distinguished from 
true fluorescence in D where it is visible as a bright yellow/orange color. Arrows numbered 3 and 
4 show a borderline positive cells when viewed through the FITC channel,which are clearly 
negative when viewed through the double bandpass filter. Arrows numbered 5 in image B show 
positive green cells with no positivity in the red channel (C) and a green appearance on the 
double bandpass filter (D) These are true positives. 
 
 
Figure 4. Colocalization of GFP and cytokeratin in lung cells.   (A) Arrows-cells labeled with 
DAPI showing the location of three nucleated cells. (B) Same field viewed through a FITC filter.  
White arrows show 2 GFP positive cells, the cell in the lower right corner is GFP negative (circle). 
(C) Same field viewed through a Texas Red filter.  Arrows indicate a positive cell stained with anti 
cytokeratin/ rhodamine. (D) Overlay of A and B showing GFP positive cytokeratin positive cell 
(red arrows). The remaining GFP positive cell (lower left corner) is negative for cytokeratin.  (E) 
3D deconvolution: Donor GFP cells are green.  All nucleated cells are counter stained with DAPI 
(blue).  Cytokeratin positive cells are shown in red. (F) Same series of deconvolution as E but 
only showing GFP positive cells. (G) Same series of deconvolution as E but only showing 
cytokeratin positive cells.  (H) Indicates colocalization of GFP and cytokeratin. (I) Composite 
picture of DAPI positive cells and GFP positive cells, showing both nucleated GFP positive and 
GFP negative cells. (J-M) Deconvolution series in clockwise rotation showing up to 180 degree 
view of the sample. 
 
Figure 5. The geographic distribution of GFP+ and GFP+/CD45+ cells in lung tissue from a 
transplanted mouse.  Tissue from a mouse transplanted with 5 million GFP+ WBM cells and 
given 2 cycles of G-CSF separated by administration of cardiotoxin into the anterior tibialis 
muscle. The mouse was irradiated with 1000 cGy prior to cell infusion and evaluated 2 months 
after the initial transplant. Phase contrast picture taken with Normarski optics in combination with 
a fluorescent image taken through DAPI, FITC and Texas Red filters.  White arrows show GFP+ 
CD45+,  Black arrows show GFP- CD45+ and green arrows show GFP+ CD45- cells.  Insert: same 
image showing only FITC. 
 
Figure 6.  GFP+CD45- cells per DAPI cell in mice transplanted with GFP+ marrow.  GFP+ 
marrow from male C57BL/6-TgN (ActbEGFP)1osb mice was cultured in IL-3, IL-6, IL-11 and steel 
factor for 0, 24 or 48 hours was injected into 900-1000 cGy treated wild type C57BL/6 mice. 
These mice received two 5 day courses of G-CSF and their lungs were evaluated 2 months after 
cell infusion. Some mice had intramuscular cardiotoxin or intratracheal bleomycin between G-
CSF courses. These results are pooled with those obtained from mice not subjected to additional 
cardiotoxin or bleomycin injury. (A) Whole unseparated marrow. Frozen sections of lungs from 
experimental mice were evaluated for GFP fluorescence and the presence of membrane CD45. 
GFP+CD45- cells were considered to be derived from donor marrow. The number of transplanted 
mice evaluated at 0, 24 and 48 hours was 16, 16 and14, respectively. The 24 hour time point in 
culture (G1/S interface) was significantly different from time 0 (p<0.05) and by 48 hours the 
values were back to baseline. The percent of GFP positive CD45- events per nucleated cell 
(DAPI) at time 0 was 5.78+/-1.6. (B) Lin-Sca-1+ cells from GFP+ mice were cultured and 
evaluated as described above. The 24 hour point was significantly different from the 0 and 48 
hour time point (p<0.05). There were 4 mice per time point. The % GFP+CD45- events per 
nucleated cell (DAPI) at time 0 was 0.98+/-0.3. (C) Combined WBM and Lin-Sca-1+ results. The 
24 hour time point is significantly different from 0 and 48 hours (p<0.05). there were a total of 20 
transplanted mice at 0 and 24 hours and 18 at 48 hours. The percent GFP+CD45- events per 
nucleated cell (DAPI) was 4.96+/-1.4. 
 
*Whole bone marrow – Anova followed by Tukey multiple comparisons compared normalized 
values at 0, 24 and 48 hours and there were significant differences between at least 2 of 3 time 
points and the Tukey test showed that there were significant differences between 0 and 24 and 
24 and 48 hours (p<0.05). there were no significant differences between o and 48 hours. 
**Lin-Sca-1+ - Anova followed by Tukey multiple comparisons compared normalized values at 0, 
24 and 48 hours and there were significant differences between at least 2 of 3 time points 
(ANOVA p=0.002) and the Tukey test showed significant differences between 0 and 24 and 24 
and 48 hours (p<0.05). There were no significant differences between 0 and 48 hours. 
*** All experiments combined – ANOVA followed by Tukey multiple comparisons compared 
normalized values at 0, 24 and 48 hours and there were significant differences between at least 2 
of 3 time points (ANOVA p=0.002) and the Tukey test showed significant differences between 0 
and 24 and 24 and 48 hours (p<0.05). there were no significant differences between 0 and 48 
hours. 
 
Figure 7.  The % GFP+CD45- lung cells/DAPI when data are calculated on a per experiment 
(culture) basis and expressed as % time 0.  A total of 6 separate experiments (58 transplanted 
mice) were analyzed. The 24 hour time point was significantly different from 0 and 48 hours 
(p<0.05). 
All experiments – ANOVA flowed by Tukey multiple comparisons compared normalized values at 
0,24 and 48 hours and there were significant differences between at least 2 0f 3 time points 
(ANOVA p=0.013) and the Tukey test showed significant differences between 0 and 24 and 24 
and 48 hours (p<0.05). There were no significant differences between 0 and 48 hours. 
 
Figure 8.  GFP+CD45- events per DAPI positive cell in a simplified irradiated mouse model. 
WBM cells from GFP+ mice were cultured in IL-3, IL-6, IL-11 and steel factor for 0 or 24 hours. 
These cells were infused into 900 cGy irradiated C57BL/6 mice and these mice were then 
sacrificed 6 weeks later and their lungs evaluated for GFP+CD45- events. There were 4 
transplanted mice per time point. The 24 hour time point was significantly different from the 0 
hour time point (p<0.004). 
 
 
 
Figure 9 .  GFP+ Cytokeratin positive events per DAPI positive cell in irradiated mice 
transplanted with GFP+ marrow. Same model as described for figure 6 The percent 
GFP+cytokeratin+ per DAPI positive cell are presented as percent time 0. These were from 
experiments with WBM transplanted mice and there were 6, 8 and 6 transplanted mice at 0, 24, 
and 48 hours, respectively. 
ANOVA followed by Tukey multiple comparisions compared normalized values at 0,24 and 48 
hours and the values were significantly different between at least 2 of 3 time points (ANOVA 
p=0.002) and the Tukey test showed significant differences between 0 and 24 and 24 and 48 
hours (p<0.05). No significant differences were not seen between 0 and 48 hours. 
   
 
 
 
Table I. Donor Marrow Cells in Lung (expressed as a percent of 0 hour control) 
 
A. Individual Transplants  
Group 24H GFP+ 24H GFP+CD45+ N 48H GFP+ 48H GFP+CD45+ N 
WBMa 129+12* 116+13 16 96+9 95+11 14 
Lin-Sca-1+ b 183+20** 153+17 4 129+24 125+24 4 
All  140+11 123+11 20 103+9 102+10 20 
 
B. Separate experiments (Individual cultures) 
Group 24H GFP+ 24H GFP+CD45+ N 48H GFP+ 48H GFP+CD45+ N 
All 155+21 137+18 6(20) 110+13 108+14 6(20) 
 
a. WBM=Whole Bone Marrow 
b. Lin-Sca-1+ = Lineage negative, Stem cell antigen-1 positive 
All combined values for WBM and Lin-Sca-1+ 
 
Data calculated as the number of events per nucleated cell (DAPI+) on lung sections and then 
normalized to percent of  0 hour. Absolute values for 0 hour (A) for WBM was 22.6+1.8 % GFP+ 
and 17+25% GFP+ CD45+ per nucleated cell (DAPI+), ,for  Lin-Sca-1+ 11+3 % GFP+ and 
9.6+2.5%  GFP+ CD45+  per nucleated cell (DAPI+). When all groups were considered 21+1.9 
GFP+% and 15.5+1.8 GFP+ CD45+ % per nucleated cell were the values at time 0 . The absolute 
values for time 0 in individual experiments (separate cultures) for  Lin-Sca-1+ was 17+3.5 % GFP+ 
and 13.7+2.7% GFP+ CD45+ per nucleated cell (DAPI+) 
* WBM  group – ANOVA followed by Tukey multiple comparisons compared normalized values at 
0, 24 and 48 hours and there were significant differences between at least 3 of 3 time points 
(ANOVA p=0.015) and the Tukey test showed significant differences between 0 and 24 and 24 
and 48 hours. 
** Lin-Sca-1+ group - ANOVA followed by Tukey multiple comparisons to compare normalized 
values at 0,24 and 48 hours showed that there were significant differences between at least 2 of 
3 time points (ANOVA p=0.026) and Tukey test showed significant differences between 0 and 24 
hours 
 
